• Paenibacillus in culture

    Antimicrobial Stewardship at UC Davis

Novel Coronavirus

The SARS-CoV-2 pandemic continues globally and locally. Please continue to practice social distancing, masking, and appropriate hand hygiene to do your part in combatting the pandemic and protect those at greatest risk. Additional information is available for patients and for UC Davis Medical Center employees

The UC Davis Antimicrobial Stewardship Program (ASP) was first established in pediatrics in 2011 and then hospital wide in 2013 in response to the growing challenge of antibiotic resistance. The CDC considers antibiotic resistance to be "one of the biggest public health challenges of our time," annually impacting 2 million plus individuals and contributing to at least 23,000 deaths. UC Davis's ASP is dedicated to assisting and educating providers with antimicrobial decision making so that antimicrobials can be used in a way that maximizes benefit, minimizes risks to individual and public health, and provides the greatest value for our healthcare dollar.    

In 2019 UC Davis ASP was honored as a "Center of Excellence (CoE)" by the Infectious Disease Society of America (IDSA), one of just twenty-three institutions to most recently receive the honor. The award is given to institutions that deliver high-quality care consistently and serve as the "gold" standard for executing novel Antimicrobial Stewardship principles. A copy of IDSA's press release can be found here. We are now one of sixty-six hospitals nationwide to receive the honor.

What's New?

CDC Publishes New Antimicrobial Resistance Threat Report

The CDC released its updated antimicrobial resistant threat report in November of this year. The first major update since 2013. The report, available here (PDF), highlights the continued and evolving impact of drug-resistant bacteria and fungi on America's public health. Although popularly known threats such as methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (C diff), and vancomycin-resistant Enterococci (VRE) remain with us and are in some cases decreasing, new and growing threats such as carbapenem-resistant Enterobacteriaceae (CRE), drug-resistant Neisseria gonorrheae, and Candida auris are now listed as "Urgent" having increasingly few antimicrobial options. The report highlights current threats as we know them in the US and various measures being taken to reduce the threats at both the local and national levels. 

Clinician Stewardship Awards

Antimicrobial Stewardship Gold Star winners

Excellent antibiotic stewards are recognized regularly throughout the year and rewards with fame and fortune in the form of acknowledgement in the ASP newsletter and a gift card to a local dining establishment. Listed below are the Gold Star for May and June:


Kristin Hoffman (Peds)

  • Costa Demiriades (Peds)
  • Chris Adams (ED)